Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
- 2020-12-08
- RCT · n = 121
- The Pediatric infectious disease journal 40(5)
- Suvi Sarlin
- Mysore V Tejesvi
- Jenni Turunen
- Petri Vänni
- Tytti Pokka
- Marjo Renko
- Terhi Tapiainen
- PubMed: 33298762
- DOI: 10.1097/inf.0000000000003016
- High evidence
- Large Human Trial
- Children
At 1 month, the abundance of otopathogens in nasopharynx was lower in K12 group compared with that in control children (34% vs. 55%, P = 0.037).
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- oral K12 product for 1 month